Abstract:Abstract Background Megakaryocytic differentiation is a complicated process regulated by a series of transcription factors in a context- and stage-dependent manner. Recent studies have suggested that krüppel-like transcription factor 2 (KLF2) is involved in the control of embryonic erythroid precursor cell differentiation and maturation. However, the function and mechanism of KLF2 in regulating megakaryocytic differentiation remain unclear. Methods The expression patterns of krüppel-like transcription factors (KLFs) during megakaryocytic differentiation were identified from public databases. Phorbol 12-myristate 13-acetate (PMA) treatment of the myeloid-erythroid-leukemic cell lines K562 and HEL were used as cellular megakaryocytic differentiation models. A lentiviral transduction system was utilized to achieve the goal of amplifying or reducing KLF2. The expression of KLF2 was examined using real-time PCR and western blot. The impact of KLF2 on the megakaryocytic differentiation of K562 cells was examined by flow cytometry, Giemsa staining, Phalloidin staining and western blot. RNA-sequencing (RNA-seq) and chromatin immunoprecipitation-sequencing (ChIP-seq) technologies were used to identify the KLF2-regulated targets. Results KLF2 is increased in the maturation process of megakaryocytes. KLF2 overexpression accelerated the PMA-induced megakaryocytic differentiation, as reflected by an increased percentage of CD41/CD61 cells, an increased number of polyploid cells, and an elevated expression of P21 and P27. KLF2 knockdown exhibited the opposite results, indicating that KLF2 knockdown suppressed the megakaryocytic differentiation. Further, combination of the RNA-seq and ChIP-seq results suggested that chimerin 1 (CHN1) and potassium voltage-gated channel subfamily Q member 5 (KCNQ5) may be target genes regulated of KLF2. Both CHN1 and KCNQ5 knockdown could block the megakaryocytic differentiation to some content. Conclusion This study implicated a regulatory role of KLF2 in megakaryocytic differentiation, which may suggest KLF2 as a target for illness with abnormal megakaryocytic differentiation.

Role For Mkl1 In Megakaryocytic Maturation

MKL1 expression and its role in megakaryocyte differentiation

Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes.

A Novel Role for Malate Dehydrogenase 1 in Acute Myeloid Leukemia Progression

Protein Arginine Methyltransferase 1 is Required for Maintenance of Normal Adult Hematopoiesis

Myeloid MKL1 Disseminates Cues to Promote Cardiac Hypertrophy in Mice

Relieving DYRK1A repression of MKL1 confers an adult-like phenotype to human infantile megakaryocytes

Megakaryocytic Leukemia 1 (mkl1) Ties the Epigenetic Machinery to Hypoxia-Induced Transactivation of Endothelin-1

Acute Myeloid Leukemia-Associated Mkl1 (Mrtf-A) is a Key Regulator of Mammary Gland Function

MR-1 blocks the megakaryocytic differentiation and transition of CML from chronic phase to blast crisis through MEK dephosphorylation

The involvement of krüppel-like transcription factor 2 in megakaryocytic differentiation induction by phorbol 12-myrestrat 13-acetate

An Intronic Deletion in Megakaryoblastic Leukemia 1 is Associated with Hyperproliferation of B Cells in Triplets with Hodgkin Lymphoma

Role of AML1a in Abnormal Proliferation and Differentiation of Murine Hematopoietic Cells

Arginine Methylation Of Rbm15 By Prmt1 Controls Alternative Splicing Of Genes Involved In Megakaryocyte Differentiation

Novel Function of PITH Domain-Containing 1 As an Activator of Internal Ribosomal Entry Site to Enhance RUNX1 Expression and Promote Megakaryocyte Differentiation

MicroRNA Expression in Maturing Murine Megakaryocytes

Clinical and Molecular Characteristics of Megakaryocytes in Myelodysplastic Syndrome

The effects of increased expression of DLK1 gene on the pathogenesis of myelodysplastic syndromes.

PRMT1-Mediated Metabolic Reprogramming Promotes Leukemogenesis

Megakaryocytic leukemia 1 directs a histone H3 lysine 4 methyltransferase complex to regulate hypoxic pulmonary hypertension.

CDK9 phosphorylates RUNX1 to promote megakaryocytic fate in megakaryocytic-erythroid progenitors